Top Markets
Coin of the day
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Pozycja w akcjach #33463
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Cena akcji
$0.5099
Ostatnia synchronizacja: 2024-10-15
Kapitalizacja rynkowa
$7.60M
Zmiana (1 dzień)
2.02%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Anew Medical, Inc. (WENA)

Kategoria

Wskaźnik P/B dla Anew Medical, Inc. (WENA)
Wskaźnik P/B na dzień August 2026 TTM: 0.63
Według najnowszych raportów finansowych i ceny akcji Anew Medical, Inc., obecny wskaźnik P/B (TTM) wynosi 0.63. Na koniec 2022 wynosił 0.79.
Historia wskaźnika P/B dla Anew Medical, Inc. od 2021 do 2026
Wskaźnik P/B na koniec każdego roku
Rok Wskaźnik P/B Zmień
2026 (TTM) 0.63 -87.86%
2023 5.20 561.31%
2022 0.79 -98.96%
2021 75.61 0.00%
Wskaźnik P/B dla podobnych firm lub konkurentów
Firma Wskaźnik P/B Różnica wskaźnika P/B Kraj
6.3419 904.26%
US
6.2413 888.33%
NL
- -
CH
- -
KR
3.4612 448.09%
BE